Authored By: Sarah
11 Jul 2024

 Antacids Market Size to grow by USD 692.3 million between 2024-2028

According to a research report “ Antacids Market” by Type (Non-symmetric antacids, Symmetric antacids) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 692.3 million, at a CAGR of  3.27% during the forecast period. In the aging population, the prevalence of gastroesophageal reflux disease (GERD) and associated symptoms such as heartburn and acidity increases. The lower esophageal sphincter, which functions to prevent stomach acid from refluxing into the esophagus, can weaken with age, allowing acid to flow back and irritate the esophageal lining. Additionally, the digestive system's natural slowing with age can contribute to increased acid production and decreased ability to neutralize stomach acid. Consequently, the global antacids market experiences significant growth due to the expanding aging demographic and the resulting demand for effective acid neutralization solutions.

Browse market data tables, figures, and in-depth TOC on “Antacids Market” by Type (Non-symmetric antacids, Symmetric antacids) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028. Download Free Sample

 

By Type, the Non-symmetric antacids segment is projected to dominate the market size in 2024

ai_market_segmentation_by

By Geography, North America  segment is expected to hold the largest market size for the year 2024

In the pharmaceutical industry, non-systemic antacids, also referred to as non-absorbable antacids, hold a significant value due to their efficacy in addressing various acid reflux conditions, including GERD and peptic ulcers. These compounds, which are primarily insoluble, do not get absorbed systemically. Instead, they work locally in the gastrointestinal tract. Non-systemic antacids are further categorized into three main classes: aluminum-containing antacids, calcium-containing antacids, and magnesium-containing antacids. Aluminum-containing antacids, consisting of aluminum hydroxide, aluminum phosphate, dihydroxy aluminum amino acate, dihydroxy aluminum sodium carbonate, and basic aluminum carbonate, neutralize stomach acid effectively. Calcium-containing antacids, which include calcium carbonate and tribasic calcium phosphate, offer quick relief from heartburn and acid indigestion. Lastly, magnesium-containing antacids, comprising magnesium carbonate, magnesium citrate, magnesium hydroxide, magnesium oxide, and magnesium phosphate, provide extended relief from acidity. The true value of non-systemic antacids lies in their synergistic effects when used in combination. By employing two or more non-systemic antacids, the therapeutic benefits are significantly amplified, making them a preferred choice for managing various acid reflux conditions.

North America is forecasted to hold the largest market size by region in 2024

The antacids market represents a significant business opportunity due to the rising prevalence of gastroesophageal reflux disease (GERD) and other digestive disorders. These conditions lead to frequent heartburn and acid reflux, driving demand for antacids. Key market players are investing in research and development to introduce innovative products, such as delayed-release formulations and combination therapies, to cater to diverse consumer needs. The market is expected to grow steadily, driven by increasing consumer awareness and healthcare expenditures.

The Antacids Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:

  • Advance Pharmaceutical Inc.
  • AmerisourceBergen Corp.
  • Bayer AG
  • Cardinal Health Inc.
  • GlaxoSmithKline Plc
  • Humco Holding Group Inc.
  • inovapharma.com
  • Johnson and Johnson Services Inc.
  • Neogen Corp.
  • Novartis AG
  • NuCare Laboratories India
  • Pfizer Inc.
  • Pharmaceutical Associates Inc.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
  • The Procter and Gamble Co.
  • United Natural Foods Inc.
  • WellSpring Pharmaceutical Corp.
.

For insights on company offerings- Request a sample report!

Research Analysis Overview

The antacids market encompasses a wide range of over-the-counter (OTC) digestive products designed to alleviate digestion problems caused by acidity. Factors such as obesity, alcohol consumption, smoking, stress, and certain medications contribute to the development of acidity problems, digestive disorders, peptic ulcers, and gastrointestinal disorders. General practitioners often recommend antacids for their patients suffering from these conditions. Antacids come in various forms, including Aluminum hydroxide, Magnesium antacids, Calcium antacids, and Sodium antacids. These medications work by neutralizing stomach acid, providing relief from symptoms such as heartburn and indigestion. However, long-term use of antacids, especially Aluminum hydroxide-based products, can lead to rebound hyperacidity and milk-alkali syndrome. Moreover, antacids are commonly used to manage conditions such as acid reflux, Barrett's esophagus, and even oesophageal cancer, although proton pump inhibitors are often prescribed for these conditions in more severe cases. The geriatric population is particularly susceptible to acidity problems due to age-related changes in the digestive system. OTC antacids are available in various forms, including Oral Tablets, Oral Liquids, and Aluminum Antacids. It is essential to follow the recommended dosage and consult a healthcare professional before using antacids for extended periods or if symptoms persist.

Market Research Overview

The antacids market encompasses a wide range of products designed to provide relief from acidity problems and digestive disorders. These include chewable tablets, liquids, mouth-melting antacids, and micro granules. Antacids contain active ingredients like aluminum hydroxide, calcium carbonate, magnesium, sodium, and alkaline agents that neutralize stomach acid. Over-the-counter antacids are popular for symptomatic disorders such as heartburn, acid reflux, and GERD. However, excessive antacid consumption can lead to dose-dependent rebound hyperacidity, hypophosphatemia, osteomalacia, and aluminum poisoning. Gastroenterologists and general practitioners often recommend antacid products for gastrointestinal issues, including peptic ulcers, inflammation, pain, and acid reflux. The pharmaceutical sector also offers injectables and acid-reducing medications like proton pump inhibitors and H2 blockers. Esophageal cancer, Barrett's esophagus, and other gastrointestinal disorders are significant indications for antacid use. Obesity, alcohol consumption, smoking, stress, and aging are common risk factors for digestive problems. Antacids are available in various forms, including retail pharmacies, online retail channels, e-commerce, and hospitals. New drugs and medical agents are continually being developed to address the growing demand for effective antacid products. It is essential to note that antacids should be used with caution, as prolonged use can lead to complications like kidney problems, diarrhea, and constipation. Patients with a history of esophageal cancer, oesophageal cancer, or other gastrointestinal disorders should consult their healthcare provider before using antacids. The market for antacids and other over-the-counter digestive products is expected to grow significantly in the coming years, driven by increasing awareness and the expanding healthcare infrastructure.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Read News Read Less
Interested in this report?
Get your sample now!
Technavio